Despite a 52% stock price correction, Cerebras Systems remains expensive at 145x forward earnings, with investors now repricing the company's growth expectations rather than its underlying business performance.
Cerebras stock has halved from its peak, yet still trades at 145x forward earnings, with profitability years away and execution risk remaining.
Cerebras Systems shares have plummeted 52% from their May peak, despite the company reporting strong revenue growth and raising its full-year outlook. While the business fundamentals have improved, the stock continues to trade at a premium 145x forward earnings, leaving little margin for error as the company works to convert its $25.4 billion backlog into actual profitability.
The stock decline reflects a market repricing of the company's valuation multiple rather than a deterioration of business fundamentals. Investors are adjusting their willingness to pay for future growth, as the stock previously traded at over 300x forward earnings.